Followers | 496 |
Posts | 29263 |
Boards Moderated | 4 |
Alias Born | 06/17/2010 |
Thursday, March 14, 2019 7:04:09 AM
The Arrangement creates:
The leading Canadian medical cannabis clinic and education centre network with 60,000 patients seen to date
A high-value, highly differentiated product portfolio of oils, capsules and sprays
Scaled production capacity and leading supply with three dedicated cultivation and product innovation facilities and the industry’s largest LP to LP cannabis supply agreement
A national and global distribution platform with provincial supply agreements, retail partnerships and a global expansion
Improved capital markets profile and liquidity, including up-listing to the TSX
A combined entity with a robust cash position
“The acquisition of Emblem rapidly accelerates the execution of Aleafia Health’s strategy and positioning as a vertically integrated, diversified cannabis company with an integrated, highly differentiated consumer ecosystem,” said CEO Geoffrey Benic. “Emblem’s product leadership in the medical and adult-use sectors and highly coveted supply agreements will perfectly complement our cannabis production and clinic operations. This is a transformative transaction that positions Aleafia Health as a global cannabis leader.”
Under the terms of the Arrangement, each former Emblem shareholder is now entitled to receive 0.8377 of a common share in the capital of Aleafia Health, for each Emblem Share held prior to the Arrangement (the “Consideration”). It is anticipated that the Emblem Shares will be delisted from the TSX Venture Exchange (“TSXV”) as of the close of trading on or about March 18, 2019.
https://mailchi.mp/aleafiainc.com/aleafia-health-and-emblem-announce-closing-of-arrangement?e=9bbb842c5f
GLTU/A!
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM